[PDF][PDF] Our experience with dermal substitute Nevelia® in the treatment of severely burned patients

H Yiğitbaş, E Yavuz, E Beken Özdemir… - Ulus Travma Acil …, 2019 - jag.journalagent.com
H Yiğitbaş, E Yavuz, E Beken Özdemir, Ö Önen, H Pençe, S Meriç, A Çelik, F Çelebi…
Ulus Travma Acil Cerrahi Derg, 2019jag.journalagent.com
ABSTRACT BACKGROUND: This research aims to retrospectively evaluate the
effectiveness and safety of dermal substitute (DS), Nevelia®, for the treatment of severely
burned patients. METHODS: Twenty severely burned patients were enrolled in this study
between May 2017 and May 2018. After escharotomy of the wound, the treatment protocol
was applied following a two-step procedure–DS implantation followed by split-thickness skin
graft (STSG) application. Need for surgery, complications, hospitalisation duration and …
Abstract
BACKGROUND: This research aims to retrospectively evaluate the effectiveness and safety of dermal substitute (DS), Nevelia®, for the treatment of severely burned patients.
METHODS: Twenty severely burned patients were enrolled in this study between May 2017 and May 2018. After escharotomy of the wound, the treatment protocol was applied following a two-step procedure–DS implantation followed by split-thickness skin graft (STSG) application. Need for surgery, complications, hospitalisation duration and overall survival were analysed.
RESULTS: Mean age was 40.1±4 (18–86) years old; female/male: 5/15. Mean burn surface area was 50.1%±2 (25–96). Two patients died under hospital treatment due to the severity of their burn trauma and comorbidities. For the rest of the cases, STSG was performed after Nevelia® at mean 21.2 days. No complications due to Nevelia® were detected. The patients were discharged with a mean total recovery of 55.2±4 days.
CONCLUSION: This study showed that Nevelia® can be used safely and effectively in severely burned patients with low complication rates and short hospital stay.
jag.journalagent.com
以上显示的是最相近的搜索结果。 查看全部搜索结果